Skip to main content
OpenTrials
Completed

NCT Number: NCT05862753

Duration and Depth of Anesthesia Induced by a Bolus of Etomidate

Induction of general anesthesia requires to be safe and to ensure a proper level of anesthesia. A proper anesthesia is sufficient to guarantee loss of consciousness and amnesia and without being too depth leading to a electroencephalogram (EEG) with burst suppression. The depth of anesthesia is monitored by the bispectral index analyse of the EEG, this allows to detect any under- or over-dose of anesthesia. The monitoring works with an unknown algorithm (patent), which evaluate the state of consciousness in the patient.

Etomidate and propofol are commonly use to ensure general anesthesia. Actually, really few litterature has objective informations about the monitoring of Etomidate. The few existant are the old ones and has just a clinical evaluation of the depth of anesthesia (loss of consciousness, loss of breathing, loss of palpebral reflex). Except the fact that these clinical evaluations come from the brain stem, and in fact are not reliable to assess the cortical activity which is reduced by etomidate.

Therefore, some anesthetists are fearful that etomidate is not sufficient to ensure a proper anesthesia to intubate the patient.

This interventionnal study has two purpose. Firstly, a survey will be conduct about the habits and beliefs when use of etomidate.

Secondly, a prospective study will be conduct to monitore with the bispectral index the depth and duration of anesthesia with etomidate.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Erasme UH

Brussels, 1070, Belgium

About this study

Protocol with randomization in one of the 2 arms (0.2 vs. 0.3 mg / kg of etomidate), blind to the investigators.

The right dosage will be prepared at the same time by a colleague anesthetist who will not participate in the study according to the randomization envelope that we will give to him earlier. To remain blind to this dosage, it will be diluted with physiological serum up to 30 ml.

These following procedures will be carried out in order:

  • Preparation by a colleague of the adequate dose of etomidate, reduced to 20 cc with physiological serum.

No premedication with benzodiazepines (xanax).

  • Standard monitoring (ECG + NIBP + SpO2)
  • Monitoring the depth of anesthesia by bispectral analysis of the electroencephalography (BIS) trace
  • Placement of a peripheral venous line (18 or 20 G) at the bend of the elbow (vein of good size to avoid potential discomfort during the injection of etomidate).
  • Preoxygenation with a face mask
  • Start remifentanil (20 μg / ml) in AIVOC mode with a site-effect concentration (Cet) of 2 μg / ml) and wait for an equilibration.
  • Injection of the induction dose of etomidate over 30 seconds.
  • After loss of consciousness, curarisation with 0,6 mg/kg (rocuronium).
  • Observation period of the depth of anesthesia. Ventilation support by light ventilation with a face mask.
  • Special attention will be paid to avoid any interference with the BIS recording (do not move the patient to set it up, do not turn on the heating blanket).

When the BIS rises above 60, the study stops. The anesthesia is then deepened by administration of propofol and is left to the discretion of the anesthesiologist in charge of the room.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA I, ASA II, schedule for minor or moderate surgery.

Exclusion criteria

  • Dependance to alcohol, to drugs, morphinique or psychotrop.
  • Epilepsia of severe CNS impairement
  • Body weight <70% or >130% to ideal body weight.

Treatment and study plan

induction by Etomidate bolus

Drug

General anesthesia induction by Etomidate bolus with different concentration in either of the two arms. First arm, has the concentration (0,2 mg/kg) commonly used of Etomidate to induce anesthesia. Second arm, has the concentration (0,3 mg/kg) usually proposed in medical literature.

Primary outcomes

  1. time to loss of consciousness

    Time frame: During general anesthesia induction

    Time for loss of consciousness after etomidate administration

  2. time to loss of palpebral reflex

    Time frame: During general anesthesia induction

    Time to loss of palpebral reflex after etomidate administration

  3. Time for BIS decrease < 60

    Time frame: During general anesthesia induction

    Time for BIS decrease < 60 after etomidate administration

  4. Duration of adequate general anesthesia

    Time frame: During general anesthesia induction

    Time spent with a bis < 60 after etomidate administration

Secondary outcomes

  1. Presence of secondary effect of etomidate, about presence of myoclonia

    Time frame: During first 15 minutes of general anesthesia

    Myoclonia

Other outcomes

  1. Presence of secondary effect of etomidate, about pain during injection

    Time frame: During first 15 minutes of general anesthesia

    Pain

Sponsors and collaborators

Lead sponsor

Erasme University Hospital

Other

Registry information

Official study title

Evaluating Duration and Depth of Anesthesia by Bispectral Index Induced by an Induction Dose of Etomidate.

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
May 17, 2023
Registry last updated
May 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.